Aldeyra Therapeutics, Inc. (NASDAQ: ALDX) today announced the pricing of an underwritten public offering of 5,250,000 shares of its ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Equity Offerings

Aldeyra Therapeutics, Inc. Announces Public Offering of Common StockSeptember 27, 2018 8:00 PM Pre-Open Movers 09/27: (CBMG) (PTGX) (HAIR) Higher; (GERN) (VERU) (BBBY) Lower (more...)September 27, 2018 9:33 AM After-Hours Stock Movers 09/26: (HAIR) (ALDX) Higher; (VERU) (BBBY) (CMTL) Lower (more...)September 26, 2018 5:07 PM Aldeyra Therapeutics (ALDX) Announces Proposed 5.25M Share Public Offering of Common StockSeptember 26, 2018 4:01 PM UPDATE: Aldeyra Therapeutics (ALDX) PT Raised to $36 at StifelSeptember 26, 2018 1:26 PM UPDATE: Aldeyra Therapeutics (ALDX) PT Raised to 'Street High' $35 at Canaccord GenuitySeptember 26, 2018 11:31 AM Aldeyra Therapeutics (ALDX) PT Raised to 'Street High' $30 at Cantor FitzgeraldSeptember 26, 2018 9:33 AM Pre-Open Movers 09/26: (ALDX) (EGY) (GPRO) Higher; (NLST) (UPL) (NKE) Lower (more...)September 26, 2018 9:28 AM Aldeyra Therapeutics (ALDX) Set to Up Higher by 60% Following Positive Results from Phase 2b Dry Eye Disease Clinical TrialSeptember 26, 2018 7:33 AM Aldeyra Therapeutics (ALDX) Reports Positive Results from Phase 2b Dry Eye Disease Clinical TrialSeptember 26, 2018 7:01 AM